SCHEMBL8089090

SCHEMBL8089090

Cc1csc(S(=O)(=O)C2(c3cc(N)nc(-c4ccc(NC(=O)NC5CCC5)cc4)n3)CC2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
RAB9A P51151 4/20 0.37
NPC1 O15118 4/20 0.37
EPHX1 P07099 3/20 0.37
GAA P10253 1/20 0.37
EPHX2 P34913 2/20 0.37
PIK3CA P42336 1/20 0.36
MTOR P42345 1/20 0.36
KIT P10721 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
FLT3 P36888 1/20 0.36
PDGFRA P16234 1/20 0.36
ALDH1A1 P00352 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8082082 0.95 PIK3CA (0.38) KDRCA12CA1CA2CA9
SCHEMBL8090804 0.88 MTOR (0.37) KDRRAB9APIK3CAMTORKMT2A
SCHEMBL3932917 0.85 ATR (0.46) GAAPIK3CAMTORALDH1A1
SCHEMBL8098772 0.85 PIK3CD (0.39) KDRRAB9APIK3CAMTORKIT
SCHEMBL8089088 0.85 PIK3CA (0.40) KDRRAB9ANPC1GAAPIK3CA
SCHEMBL8099411 0.84 CA12 (0.44) KDRCA12CA1CA2CA9
SCHEMBL8096192 0.83 PIK3CD (0.36) KDRRAB9APIK3CAMTORFLT3
SCHEMBL8085149 0.83 PIK3CA (0.39) KDRRAB9ANPC1GAAPIK3CA
SCHEMBL8096194 0.83 KDM4E (0.39) KDRRAB9ANPC1GAAPIK3CA
SCHEMBL8084833 0.83 CA12 (0.43) KDRCA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed